BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33254441)

  • 21. Berberine combined with stachyose induces better glycometabolism than berberine alone through modulating gut microbiota and fecal metabolomics in diabetic mice.
    Li CN; Wang X; Lei L; Liu MZ; Li RC; Sun SJ; Liu SN; Huan Y; Zhou T; Liu Q; Cao H; Bai GL; Han YW; Shen ZF
    Phytother Res; 2020 May; 34(5):1166-1174. PubMed ID: 31833107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Berberine attenuates high glucose-induced fibrosis by activating the G protein-coupled bile acid receptor TGR5 and repressing the S1P2/MAPK signaling pathway in glomerular mesangial cells.
    Yang Z; Li J; Xiong F; Huang J; Chen C; Liu P; Huang H
    Exp Cell Res; 2016 Aug; 346(2):241-7. PubMed ID: 27292312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-response effect of berberine on bile acid profile and gut microbiota in mice.
    Guo Y; Zhang Y; Huang W; Selwyn FP; Klaassen CD
    BMC Complement Altern Med; 2016 Oct; 16(1):394. PubMed ID: 27756364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ursolic acid activates the TGR5 receptor to enhance GLP-1 secretion in type 1-like diabetic rats.
    Lo SH; Li Y; Cheng KC; Niu CS; Cheng JT; Niu HS
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Nov; 390(11):1097-1104. PubMed ID: 28756460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Berberine Directly Affects the Gut Microbiota to Promote Intestinal Farnesoid X Receptor Activation.
    Tian Y; Cai J; Gui W; Nichols RG; Koo I; Zhang J; Anitha M; Patterson AD
    Drug Metab Dispos; 2019 Feb; 47(2):86-93. PubMed ID: 30409838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota.
    Wang Y; Liu H; Zheng M; Yang Y; Ren H; Kong Y; Wang S; Wang J; Jiang Y; Yang J; Shan C
    Front Endocrinol (Lausanne); 2021; 12():609134. PubMed ID: 34025574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis.
    Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q
    Front Immunol; 2020; 11():588079. PubMed ID: 33072135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects.
    Chaudhari SN; Harris DA; Aliakbarian H; Luo JN; Henke MT; Subramaniam R; Vernon AH; Tavakkoli A; Sheu EG; Devlin AS
    Nat Chem Biol; 2021 Jan; 17(1):20-29. PubMed ID: 32747812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary Fiber Is Essential to Maintain Intestinal Size, L-Cell Secretion, and Intestinal Integrity in Mice.
    Hunt JE; Hartmann B; Schoonjans K; Holst JJ; Kissow H
    Front Endocrinol (Lausanne); 2021; 12():640602. PubMed ID: 33716991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice.
    Wang Y; Dilidaxi D; Wu Y; Sailike J; Sun X; Nabi XH
    Biomed Pharmacother; 2020 May; 125():109914. PubMed ID: 32035395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin Compensates GLP-1 Deficiency via the Microbiota-Bile Acids Axis and Modulation in Functional Crosstalk between TGR5 and FXR in ob/ob Mice.
    Tian F; Chen T; Xu W; Fan Y; Feng X; Huang Q; Chen J
    Mol Nutr Food Res; 2023 Nov; 67(22):e2300195. PubMed ID: 37712101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.
    Katsuma S; Hirasawa A; Tsujimoto G
    Biochem Biophys Res Commun; 2005 Apr; 329(1):386-90. PubMed ID: 15721318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of combination treatment with metformin and berberine on hypoglycemic activity and gut microbiota modulation in db/db mice.
    Lyu Y; Li D; Yuan X; Li Z; Zhang J; Ming X; Shaw PC; Zhang C; Kong APS; Zuo Z
    Phytomedicine; 2022 Jul; 101():154099. PubMed ID: 35489323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic G protein-coupled bile acid receptor agonists and bile acids act via basolateral receptors in ileal and colonic mucosa.
    Tough IR; Schwartz TW; Cox HM
    Neurogastroenterol Motil; 2020 Dec; 32(12):e13943. PubMed ID: 32656959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kazak faecal microbiota transplantation induces short-chain fatty acids that promote glucagon-like peptide-1 secretion by regulating gut microbiota in
    Han X; Wang Y; Zhang P; Zhu M; Li L; Mao X; Sha X; Li L
    Pharm Biol; 2021 Dec; 59(1):1077-1087. PubMed ID: 34392792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice.
    Li Q; Li M; Li F; Zhou W; Dang Y; Zhang L; Ji G
    J Ethnopharmacol; 2020 Aug; 258():112896. PubMed ID: 32325178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Berberine activates bitter taste responses of enteroendocrine STC-1 cells.
    Yue X; Liang J; Gu F; Du D; Chen F
    Mol Cell Biochem; 2018 Oct; 447(1-2):21-32. PubMed ID: 29363059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel TGR5 Activator WB403 Promotes GLP-1 Secretion and Preserves Pancreatic β-Cells in Type 2 Diabetic Mice.
    Zheng C; Zhou W; Wang T; You P; Zhao Y; Yang Y; Wang X; Luo J; Chen Y; Liu M; Chen H
    PLoS One; 2015; 10(7):e0134051. PubMed ID: 26208278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
    Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
    Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.